Nausea

Acamprosate and oral naltrexone were associated with significantly improved alcohol consumption outcomes compared with placebo and could be used alongside psychosocial interventions as first-line treatment for alcohol use disorder.

The FDA has granted conditional use with magnetic resonance imaging to Enterra Medical’s implantable electrical stimulation device for management of symptoms associated with gastroparesis, according to a company release.

Hypertension is also known as high blood pressure. It is defined as transitory (short-lived) or chronic elevation of the blood pressure in the arteries. This elevation may lead to cardiovascular damage. When left untreated, the damage to the circulatory system can cause heart attack, stroke, heart failure, heart disease and kidney failure.

Pure essential oils can reduce incidence of chemotherapy-induced nausea and vomiting among individuals who undergo bone marrow transplant, according to study results.

Use of different antibody-drug conjugates resulted in a variety of significant and in some cases serious treatment‐associated adverse events, according to results of a systematic review and meta-analysis published in Cancer.

A systematic literature review found the use of intraoperative ketamine during total hip and knee arthroplasty may reduce postoperative opioid consumption, pain, nausea and vomiting; however, it should be used cautiously in older patients.

Nausea is among the most common and distressing symptoms experienced by children and adolescents with cancer.

Heron Therapeutics Inc. announced it has received FDA approval of Aponvie injectable emulsion, also known as HTX-019, for IV use for the prevention of postoperative nausea and vomiting in adults.

Obefazimod improved moderate to severe ulcerative colitis compared with placebo in patients with documented nonresponse or intolerance to previous treatment, according to new data published in The Lancet Gastroenterology & Hepatology.

Clinicians consistently underreported and caregivers overreported symptomatic adverse events that children undergoing cancer treatment in clinical trials experienced, according to study results published in Journal of Clinical Oncology.